Chronic spontaneous urticaria

CSU · Immunology · 2 drugs · 3 indications

Chronic hives without identifiable trigger.
Competitive Landscape (2 drugs)
DrugCompanyMechanismModalityRouteStage
XolairROG.SW, NVSIgE antagonistAntibodySCAPPROVED
DupixentREGNIL-4Rα inhibitor (monoclonal antibody)Monoclonal antibodySCAPPROVED
Indications (3)
CSU
Xolair APPROVED
Chronic spontaneous urticaria (CSU)
Dupixent PHASE3
Chronic pruritus of unknown origin
Dupixent PHASE3
Upcoming Catalysts
Dupixent - CSU - Ph3 Topline (LIBERTY-CSU CUPID)CLINICAL
REGN2026
Xolair - Biosimilar CompetitionCOMPETITIVE
ROG.SWH2 2026
Data from Supabase · Updated 2026-03-24